Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this Internet Enduring Material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPLM Designation Statement: This Internet Enduring Material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1 management hour toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.
Session Description: This session will address the legal risks associated with antipsychotics. The applicable federal regulations and CMS' recent initiatives will be explored on a practical level. Among the presentation methods will be actual cases where nursing facilities and physicians were held accountable for antipsychotic use considered inappropriate from a clinical and legal perspective. The presenter represented CMS Region III for more than 12 years and has represented SNFs for the past two years. He has handled many cases, representing both CMS and providers, bringing a unique perspective to this area.
Appreciate how the Centers for Medicare and Medicaid Services (CMS) and the judicial system treats regulatory violations involving unnecessary drugs and inappropriate antipsychotic use.
Recognize that apart from the CMS survey and regulatory process, additional civil liability may exist.
Describe what CMS and surveyors will expect to see in nursing facilities and physician practices regarding antipsychotics.
Become more effective medical directors and attending physicians by playing a central role in antipsychotic reduction.